Lidia Mongay

Lidia Mongay, MD PhD MBA, is a highly experienced professional in clinical development and medical strategy, currently serving as a Senior Clinical Development Leader at Bayer since November 2015. Prior roles include Global Clinical Leader at Novartis Oncology, where Lidia led a clinical team for hematology and solid tumor phases I-III trials, and Global Medical Director for Glivec/Tasigna. With extensive experience in market access, product launch, and medical consulting at both Novartis Oncology and Procter & Gamble, Lidia has significantly contributed to the strategic development and successful market implementation of pharmaceutical products. Academic qualifications include an MD in Immunology, a PhD in Cellular and Molecular Biology, and an MBA in Healthcare Management.